Drug delivery from gelatin-based systems

Expert Opinion on Drug Delivery

Volumn 12, Issue 9, 2015, Pages 1547-1563

  Foox, Maytal ^a   Zilberman, Meital ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

fibers; gelatin; hydrogels; microparticles; nanoparticles; tissue bioadhesive

Indexed keywords

ADHESIVE AGENT; BIOADHESIVE; GELATIN; LIPOSOME; NANOPARTICLE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; DRUG CARRIER; EXCIPIENT; HYDROGEL;

ANALGESIA; CELL EXPANSION; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG DELIVERY SYSTEM; FIBER; HUMAN; HYDROGEL; NONHUMAN; REVIEW; WOUND HEALING; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GELATIN; HUMANS; HYDROGELS; NANOPARTICLES;

EID: 84939629306     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2015.1037272     Document Type: Review

References (126)

1. Burke CJ, Hsu TA, Volkin DB. Formulation, stability, and delivery of live attenuated vaccines for human use. Crit Rev Ther Drug Carrier Syst 1999; 16: 1-83
2. Karim AA, Bhat R. Fish gelatin: properties, challenges, and prospects as an alternative to mammalian gelatins. Food Hydrocoll 2009; 23: 563-76
3. Pollack SV. Silicone, fibrel, and collagen implantation for facial lines and wrinkles. J Dermatol Surg Oncol 1990; 16: 957-61
4. Rao KP. Recent developments of collagenbased materials for medical applications and drug delivery systems. J Biomater Sci Polym Ed 1995; 7: 623-45
5. Saddler JM, Horsey PJ. The new generation gelatins. A review of their history, manufacture and properties. Anesthesia 1987; 42: 998-1004
6. GMIA. Gelatin handbook. Gelatin Manufact. Inst. Am., New York; [online] 2012. Available from: http://www.gelatin-gmia.com/html/qanda.html. [Retrieved 22 September 2012]
7. GME. Gelatin Manufacturers of Europe. 2008. Available from: http://www.gelatine.org/en/gelatine/overview/127.htm. [Accessed 15 March 2008]
8. Asghar A, Henrickson RL. Chemical, biochemical, functional, and nutritional characteristics of collagen in food systems. Adv Food Res 1982; 28: 231-372
9. Farrugia CA, Farrugia IV, Groves MJ. Comparison of the molecular weight distribution of gelatin fractions by size-exclusion chromatography and light scattering. Pharm Pharmacol Commun 1998; 4: 559-62
10. Courts A. The N-terminal amino acid residues of gelatin. 2. Thermal degradation. Biochem J 1954; 58: 74
11. Wilesmith JW, Ryan JBM, Atkinson MJ. Bovine spongiform encephalopathy: epidemiological studies on the origin. Vet Rec 1991; 128: 199-203
12. Schrieber R, Gareis H. Gelatine handbook. Wiley-VCH GmbH & Co; Weinhem: 2007
13. Aas K. Studies of hypersensitivity to fish. A clinical study. Int Arch Allergy Appl Immunol 1966; 29: 346
14. Sakaguch M, Toda M, Ebihara T, et al. IgE antibody to fish gelatin (type I collagen) in patients with fish allergy. J Allergy Clin Immunol 2000; 106: 579-84
15. Olsen D, Yang C, Bodo M, et al. Recombinant collagen and gelatin for drug delivery. Adv Drug Deliv Rev 2003; 55: 1547-67
16. Bigi A, Cojazzi G, Panzavolta S, et al. Mechanical and thermal properties of gelatin films at different degrees of glutaraldehyde crosslinking. Biomaterials 2001; 22: 763-8
17. Vandelli MA, Romagnoli M, Monti A, et al. Microwave-treated gelatin microspheres as drug delivery system. J Control Release 2004; 96: 67-84
18. Welz MM, Ofner CM. Examination of self-cross-linked gelatin as a hydrogel for controlled release. J Pharm Sci 1992; 81: 85-90
19. Digenis GA, Gold TB, Shah VP. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci 1994; 83: 915-21
20. Raymond G, Degennaro M, Mikeal R. Preparation of gelatin: phenytoin sodium microsphers: an in vitro and in vivo evaluation. Drug Dev Ind Pharm 1990; 16: 1025-51
21. Vandelli MA, Rivasi F, Guerra P, et al. Gelatin microspheres cross-linked with D, L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. Int J Pharm 2001; 215: 175-84
22. Sung HW, Huang DM, Chang WH, et al. Gelatin-derived bioadhesives for closing skin wounds: an in vivo study. J Biomater Sci Polym Ed 1999; 10: 751-71
23. Tomihata K, Ikada Y. Cross-linking of gelatin with carbodiimides. Tissue Eng 1996; 2: 307-13
24. Hoare TR, Kohane DS. Hydrogels in drug delivery: progress and challenges. Polymer (Guildf) 2008; 49: 1993-2007
25. Kuijpers AJ, Engbers GH, Krijgsveld J, et al. Cross-linking and characterisation of gelatin matrices for biomedical applications. J Biomater Sci Polym Ed 2000; 11: 225-43
26. Tomihata K, Burczak K, Shiraki K, Ikada Y. Cross-linking and biodegradation of native and denatured collagen. Polym Biol Biomed Significance 1994; 540: 275-86
27. Petite H, Frei V, Huc A, Herbage D. Use of diphenylphosphorylazide for cross-linking collagen-based biomaterials. J Biomed Mater Res 1994; 28: 159-65
28. Khor E. Methods for the treatment of collagenous tissues for bioprostheses. Biomaterials 1997; 18: 95-105
29. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev 1999; 99: 3181-98
30. Olde Damink LHH, Dijkstra PJ, Van Luyn MJA, et al. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 1996; 17: 765-73
31. Lee JM, Edwards HHL, Pereira CA, Samii SI. Crosslinking of tissue-derived biomaterials in 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC). J Mater Sci 1996; 7: 531-41
32. Chiono V, Pulieri E, Vozzi G, et al. Genipin-cross-linked chitosan/gelatin blends for biomedical applications. J Mater Sci 2008; 19: 889-98
33. Sung HW, Huang DM. Chang, WH, et al. Evaluation of gelatin hydrogel cross-linked with various crosslinking agents as bioadhesives: in vitro study. J Biomed Mater Res 1999; 46: 520-30
34. Sung HW, Huang RN, Huang LL, Tsai CC. In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. J Biomater Sci Polym Ed 1999; 10: 63-78
35. Tsai CC, Huang RN, Sung HW, Liang HC. In vitro evaluation of the genotoxicity of a naturally occurring crosslinking agent (genipin) for biologic tissue fixation. J Biomed Mater Res 2000; 52: 58-65
36. Esposito E, Cortesi R, Nastruzzi C. Gelatin microspheres: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials 1996; 17: 2009-20
37. Di Silvio L, Gurav N, Kayser MV, et al. Biodegradable microspheres: a new delivery system for growth hormone. Biomaterials 1994; 15: 931-6
38. Liang HC, Chang WH, Liang HF, et al. Crosslinking structures of gelatin hydrogels cross-linked with genipin or a water-soluble carbodiimide. J Appl Polym Sci 2004; 91: 4017-26
39. Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005; 109: 256-74
40. Knop K, Hoogenboom R, Fischer D, Schubert US. Poly (ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed 2010; 49: 6288-308
41. Meng ZX, Xu XX, Zheng W, et al. Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system. Colloids Surf B Biointerfaces 2011; 84: 97-102
42. Lee EJ, Khan SA, Park JK, Lim KH. Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation. Bioprocess Biosyst Eng 2012; 35: 297-307
43. Rajan M, Raj V. Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery. Carbohydr Polym 2013; 98: 951-8
44. Kumar R, Nagarwal RC, Dhanawat M, Pandit JK. In-vitro and in-vivo study of indomethacin loaded gelatin nanoparticles. J Biomed Nanotechnol 2011; 7: 325-33
45. Narayanan D, Koyakutty M, Nair S, Menon D. Poly-(ethylene glycol) modified gelatin nanoparticles for sustained delivery of the anti-inflammatory drug Ibuprofen-Sodium: an in vitro and in vivo analysis. Nanomedicine 2013; 9: 818-28
46. Madan J, Pandey RS, Jain UK, et al. Sterically stabilized gelatin microassemblies of noscapine enhance cytotoxicity, apoptosis and drug delivery in lung cancer cells. Colloids Surf B Biointerfaces 2013; 107: 235-44
47. Lee SJ, Yhee JY, Kim SH, et al. Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice. J Control Release 2013; 172: 358-66
48. Li WM, Chen SY, Liu DM. In situ doxorubicin-CaP shell formation on amphiphilic gelatin-iron oxide core as a multifunctional drug delivery system with improved cytocompatibility, pH-responsive drug release and MR imaging. Acta Biomater 2013; 9: 5360-8
49. Wang J, Wu W, Zhang Y, et al. The combined effects of size and surface chemistry on the accumulation of boronic acid-rich protein nanoparticles in tumors. Biomaterials 2014; 35: 866-78
50. Bonner DK, Zhao X, Buss H, et al. Crosslinked linear polyethylenimine enhances delivery of DNA to the cytoplasm. J Control Release 2013; 167: 101-7
51. Santoro M, Tatara AM, Mikos AG. Gelatin carriers for drug and cell delivery in tissue engineering. J Control Release 2014; 190: 210-18
52. Tabata Y, Ikada Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 1998; 31: 287-301
53. Lu Z, Yeh TK, Tsai M, et al. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res 2004; 10: 7677-84
54. Wang H, Zou Q, Boerman OC, et al. Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo. J Control Release 2013; 166: 172-81
55. Kim YH, Furuya H, Tabata Y. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. Biomaterials 2014; 35: 214-24
56. Kimura Y, Tabata Y. Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 2010; 21: 37-51
57. Saito T, Tabata Y. Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy. Acta Biomater 2012; 8: 646-52
58. Tan H, Huang D, Lao L, Gao C. RGD modified PLGA/gelatin microspheres as microcarriers for chondrocyte delivery. J Biomed Mater Res B Appl Biomater 2009; 91: 228-38
59. Huang S, Wang Y, Liang T, et al. Fabrication and characterization of a novel microparticle with gyrus-patterned surface and growth factor delivery for cartilage tissue engineering. Mater Sci Eng C 2009; 29: 1351-6
60. Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2006; 2: 8-21
61. Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002; 6: 319-27
62. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001; 47: 65-81
63. Knight CG. Liposomes, from physical structure to therapeutic applications. Elsevier; Amsterdam: 1981
64. Mastrobattista E, Koning GA, van Bloois L, et al. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J Biol Chem 2002; 277: 27135-43
65. Schnyder A, Huwyler J. Drug transport to brain with targeted liposomes. NeuroRx 2005; 2: 99-107
66. Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006; 1: 297
67. Chen C, Han D, Cai C, Tang X. An overview of liposome lyophilization and its future potential. J Control Release 2010; 142: 299-311
68. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001; 70: 1-20
69. Mufamadi MS, Pillay V, Choonara YE, et al. A review on composite liposomal technologies for specialized drug delivery. J Drug Deliv 2011; 2011: 939851
70. Kaur A, Jain S, Tiwary A. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation. Acta Pharm 2008; 58: 61-74
71. Shenoy DB, Amiji MM. Poly (ethylene oxide)-modified poly (epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 2005; 293: 261-70
72. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010; 75: 1-18
73. Li JK, Wang N, Wu XS. Gelatin nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method. J Microencapsul 1998; 15: 163-72
74. Yarchoan R, Mitsuya H, Thomas RV, et al. In vivo activity against HIV and favorable toxicity profile of 2, 3-dideoxyinosine. Science 1989; 245: 412-15
75. Bajpai AK, Choubey J. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J Mater Sci 2006; 17: 345-58
76. Lee ES, Gao Z, Bae YH. Recent progress in tumor pH targeting nanotechnology. J Control Release 2008; 132: 164-70
77. Zillies J, Coester C. Evaluating gelatin based nanoparticles as a carrier system for double stranded oligonucleotides. J Pharm Pharm Sci 2005; 7: 17-21
78. Nguyen AH, McKinney J, Miller T, et al. Gelatin methacrylate microspheres for growth factor controlled release. Acta Biomater 2015; 13: 101-10
79. Forni F, Vandelli MA, Cameroni R. Influence of drug loading level on drug release and dynamic swelling of cross-linked gelatin microspheres Journal of microencapsulation. 1992; 9: 29-39
80. Ozkizilcik A, Tuzlakoglu K. A new method for the production of gelatin microparticles for controlled protein release from porous polymeric scaffolds. J Tissue Eng Regen Med 2014; 8: 242-7
81. Kempen DH, Lu L, Hefferan TE, et al. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008; 29: 3245-52
82. Franssen O, Hennink WE. A novel preparation method for polymeric microparticles without the use of organic solvents. Int J Pharm 1998; 168: 1-7
83. Dinarvand R, Rahmani E, Farbod E. Gelatin microspheres for the controlled release of all-trans-retinoic acid topical formulation and drug delivery evaluation. Iranian J Pharm Res 2003; 1: 47-50
84. Bruschi ML, Cardoso MLC, Lucchesi MB, Gremião MPD. Gelatin microparticles containing propolis obtained by spray-drying technique: preparation and characterization. Int J Pharm 2003; 264: 45-55
85. Holland TA, Tabata Y, Mikos AG. Dual growth factor delivery from degradable oligo (poly (ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. Journal of Control Release 2005; 101: 111-25
86. Hoch E, Schuh C, Hirth T, et al. Stiff gelatin hydrogels can be photo-chemically synthesized from low viscous gelatin solutions using molecularly functionalized gelatin with a high degree of methacrylation. J Mater Sci 2012; 23: 2607-17
87. Solorio LD, Vieregge EL, Dhami CD, et al. Engineered cartilage via self-assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-beta1. J Control Release 2012; 158: 224-32
88. Patel ZS, Ueda H, Yamamoto M, et al. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res 2008; 25: 2370-8
89. Patel ZS, Yamamoto M, Ueda H, et al. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater 2008; 4: 1126-38
90. Manca ML, Cassano R, Valenti D, et al. Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis. J Pharm Pharmacol 2013; 65: 1302-11
91. Bangham AD, Hill MW, Miller NGA. Preparation and use of liposomes as models of biological membranes. Springer; US: 1974. p. 1-68
92. DiTizio V, Ferguson GW, Mittelman MW, et al. A liposomal hydrogel for the prevention of bacterial adhesion to catheters. Biomaterials 1998; 19: 1877-84
93. Peptu C, Popa M, Antimisiaris SG. Release of liposome-encapsulated calcein from liposome entrapping gelatin-carboxymethylcellulose films: a presentation of different possibilities. J Nanosci Nanotechnol 2008; 8: 2249-58
94. Burke SA, Ritter-Jones M, Lee BP, Messersmith PB. Thermal gelation and tissue adhesion of biomimetic hydrogels. Biomed Mater 2007; 2: 203
95. Martins A, Araújo JV, Reis RL, Neves NM. Electrospun nanostructured scaffolds for tissue engineering applications. Nanomedicine 2007; 2: 929-42
96. Li W J, Laurencin CT, Caterson EJ, et al. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 2002; 60: 613-21
97. Lin WH, Tsai WB. In situ UV-crosslinking gelatin electrospun fibers for tissue engineering applications. Biofabrication 2013; 5: 035008
98. Grigsby WJ, Kadla JF. Evaluating poly (lactic acid) fiber reinforcement with modified tannins. Macromol Mater Eng 2014; 299: 368-78
99. Ingildeev D, Hermanutz F, Bredereck K, Effenberger F. Novel cellulose/polymer blend fibers obtained using ionic liquids. Macromol Mater Eng 2012; 297: 585-94
100. Kotek R, Jung D, Tonelli AE, Vasanthan N. Novel methods for obtaining high modulus aliphatic polyamide fibers. J Macromol Sci Part C Polym Rev 2005; 45: 201-30
101. Fukae R, Maekawa A, Sangen O. Gel-spinning and drawing of gelatin. Polymer (Guildf) 2005; 46: 11193-4
102. Midorikawa T, Lawal OS, Sasaki Y, Fukae R. Structure and physical properties of gelatin fibers prepared by gel-spinning in ethylene glycol. J Appl Polym Sci 2012; 125: E332-8
103. Stoessel PR, Raso RA, Kaufmann T, et al. Fibers mechanically similar to sheep wool obtained by wet spinning of gelatin and optional plasticizers. Macromol Mater Eng 2014; 300: 234-41
104. Zeugolis DI, Khew ST, Yew ES, et al. Electro-spinning of pure collagen nano-fibres-Just an expensive way to make gelatin? Biomaterials 2008; 29: 2293-305
105. Persano L, Camposeo A, Tekmen C, Pisignano D. Industrial upscaling of electrospinning and applications of polymer nanofibers: a review. Macromol Mater Eng 2013; 298: 504-20
106. Valipouri A, Ravandi SH, Pishevar AR. A novel method for manufacturing nanofibers. Fibers Polym 2013; 14: 941-9
107. Mahalingam S, Edirisinghe M. Forming of polymer nanofibers by a pressurised gyration process. Macromol Rapid Commun 2013; 34: 1134-9
108. Chakraborty S, Liao I, Adler A, Leong KW. Electrohydrodynamics: a facile technique to fabricate drug delivery systems. Adv Drug Deliv Rev 2009; 61: 1043-54
109. Lakshminarayanan R, Sridhar R, Loh XJ, et al. Interaction of gelatin with polyenes modulates antifungal activity and biocompatibility of electrospun fiber mats. Int J Nanomedicine 2014; 9: 2439
110. Del Gaudio C, Baiguera S, Boieri M, et al. Induction of angiogenesis using VEGF releasing genipin-cross-linked electrospun gelatin mats. Biomaterials 2013; 34: 7754-65
111. Conte U, Colombo P, Gazzaniga A, et al. Swelling-activated drug delivery systems. Biomaterials 1988; 9: 489-93
112. Jhon MS, Andrade JD. Water and hydrogels. J Biomed Mater Res 1973; 7: 509-22
113. Jen AC, Wake MC, Mikos AG. Review: Hydrogels for cell immobilization. Biotechnol Bioeng 1996; 50: 357-64
114. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 2001; 53: 321-39
115. Kim S, Park K. Tailor-made hydrogels for tumor delivery. In: Kratz F, Senter P, Steinhagen H, editors, Drug delivery in oncology: from basic research to cancer therapy. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany;. 2011. p. 1071-97
116. Wolinsky JB, Colson YL, Grinstaff MW. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release 2012; 159: 14-26
117. Kamath K, Park K. Biodegradable hydrogels in drug delivery. Adv Drug Deliv Rev 1993; 11: 59-84
118. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002; 54: 3-12
119. Lin H, Cheng AWM, Alexander PG, et al. Cartilage tissue engineering application of injectable gelatin hydrogel with in situ visible-light-activated gelation capability in both air and aqueous solution. Tissue Eng Part A 2014; 20: 2402-11
120. Wang T, Zhu XK, Xue XT, Wu DY. Hydrogel sheets of chitosan, honey and gelatin as burn wound dressings. Carbohydr Polym 2012; 88: 75-83
121. Oun R, Plumb JA, Wheate NJ. A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit [7] uril, gelatin and polyvinyl alcohol. J Inorg Biochem 2014; 134: 100-5
122. Cohen B, Shefy-Peleg A, Zilberman M. Novel gelatin/alginate soft tissue adhesives loaded with drugs for pain management: structure and properties. J Biomater Sci Polym Ed 2014; 25: 224-40
123. Foox M, Raz-Pasteur A, Berdicevsky I, et al. In vitro microbial inhibition, bonding strength, and cellular response to novel gelatin-alginate antibiotic-releasing soft tissue adhesives. Polym Adv Technol 2014; 25: 516-24
124. Bae SK, Sung TH, Kim JD. A soft-tissue gelatin bioadhesive reinforced with a proteinoid. J Adhes Sci Technol 2002; 16: 361-72
125. Gombotz WR, Wee SF. Protein release from alginate matrices. Adv Drug Deliv Rev 2012; 64: 194-205
126. Otterlei M, Sundan A, Skjåk-Bræk G, et al. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun 1993; 61: 1917-25